Chanticleer Holdings Announces Merger Agreement with Sonnet BioTherapeutics to Advance Pipeline of Novel Immune Therapeutics
– Transaction to Accelerate Sonnet’s Growing Pipeline of Oncology Candidates –– Initiation of Two New Clinical Programs Expected in 2020 […]